ATE231851T1 - 6-o-alkyl erythronolid-b derivate - Google Patents

6-o-alkyl erythronolid-b derivate

Info

Publication number
ATE231851T1
ATE231851T1 AT98959480T AT98959480T ATE231851T1 AT E231851 T1 ATE231851 T1 AT E231851T1 AT 98959480 T AT98959480 T AT 98959480T AT 98959480 T AT98959480 T AT 98959480T AT E231851 T1 ATE231851 T1 AT E231851T1
Authority
AT
Austria
Prior art keywords
erythronolide
derivatives
alkyl
alkyl derivatives
erythromycin
Prior art date
Application number
AT98959480T
Other languages
English (en)
Inventor
Howard E Gracey
Stephen H Montgomery
David A Riley
Jih-Hua Liu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE231851T1 publication Critical patent/ATE231851T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
AT98959480T 1997-12-01 1998-11-17 6-o-alkyl erythronolid-b derivate ATE231851T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/980,919 US5919916A (en) 1997-12-01 1997-12-01 6-O-alkyl derivatives of erythronolide B
PCT/US1998/024497 WO1999028311A1 (en) 1997-12-01 1998-11-17 6-o-alkyl derivatives of erythronolide b

Publications (1)

Publication Number Publication Date
ATE231851T1 true ATE231851T1 (de) 2003-02-15

Family

ID=25527957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959480T ATE231851T1 (de) 1997-12-01 1998-11-17 6-o-alkyl erythronolid-b derivate

Country Status (13)

Country Link
US (1) US5919916A (de)
EP (1) EP1040107B1 (de)
JP (1) JP2001524549A (de)
KR (1) KR20010032636A (de)
AT (1) ATE231851T1 (de)
AU (1) AU1526899A (de)
CA (1) CA2309977A1 (de)
DE (1) DE69811120T2 (de)
DK (1) DK1040107T3 (de)
ES (1) ES2191982T3 (de)
IL (1) IL135792A0 (de)
PT (1) PT1040107E (de)
WO (1) WO1999028311A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
WO2001064224A1 (en) * 2000-02-29 2001-09-07 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
EP1469008B1 (de) * 2000-03-15 2006-08-30 Hanmi Pharm. Co., Ltd. Verfahren zur Herstellung von Clarythromycin mit nicht pharmazeutischer Qualität
KR20000037126A (ko) * 2000-04-08 2000-07-05 김용규 6-메틸 에리스로마이신 ａ의 제조방법
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6455680B1 (en) 2000-12-21 2002-09-24 Abbott Laboratories Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
TWI246515B (en) 2001-05-30 2006-01-01 Abbott Lab An arylation method for the functionalization of O-allyl erythromycin derivatives
US7825200B2 (en) * 2003-02-28 2010-11-02 The Regents Of The University Of California Controlled free radical grafting from polyolefins
ES2552682T3 (es) 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
AU2004258944B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004264939A1 (en) 2003-08-11 2005-02-24 Middlebrook Pharmaceuticals, Inc. Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1771158A4 (de) 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp Tablette für pulsierte abgabe
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
EP2214484A4 (de) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc Verfahren zur herstellung von antibakteriellen makrolid-wirkstoffen
CN105616437A (zh) 2008-10-24 2016-06-01 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (de) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Verfahren zur behandlung von malaria, tuberkulose und mac-erkrankungen
CA2793884C (en) 2010-03-22 2019-09-10 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
DK2571506T3 (en) 2010-05-20 2017-08-28 Cempra Pharmaceuticals Inc PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
AU2013239696C1 (en) 2012-03-27 2018-11-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (de) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Verfahren zur behandlung von atemwegserkrankungen und formulierungen dafür
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697547A (en) * 1970-12-18 1972-10-10 Abbott Lab Erythronolide b derivatives
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS5896097A (ja) * 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンｂ誘導体
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
JPH08149986A (ja) * 1994-09-28 1996-06-11 Taisho Pharmaceut Co Ltd １２−ヒドロキシ−６−ｏ−アルキルエリスロマイシン及びその類縁体の製造方法
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making

Also Published As

Publication number Publication date
WO1999028311A1 (en) 1999-06-10
KR20010032636A (ko) 2001-04-25
CA2309977A1 (en) 1999-06-10
AU1526899A (en) 1999-06-16
US5919916A (en) 1999-07-06
IL135792A0 (en) 2001-05-20
DK1040107T3 (da) 2003-05-05
JP2001524549A (ja) 2001-12-04
PT1040107E (pt) 2003-06-30
ES2191982T3 (es) 2003-09-16
EP1040107B1 (de) 2003-01-29
EP1040107A1 (de) 2000-10-04
DE69811120D1 (de) 2003-03-06
DE69811120T2 (de) 2003-10-09

Similar Documents

Publication Publication Date Title
DE69811120D1 (de) 6-o-alkyl erythronolid-b derivate
DE69726714T2 (de) 9-oximsilyl erythromycin a derivate
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
CY1106743T1 (el) Μεθοδος παρασκευης θειαμεθοξαμης
NO904839D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
DE69709938D1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO913745L (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
NO901070D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
UA8017A1 (uk) Спосіб отримання похідних хінолінкарбонової кислоти
NO924028L (no) Forbedret fremgangsmaate for fremstilling av substituerte indolonderivater
NO901832L (no) Fremgangsmaate for fremstilling av polyketon.
NO903780L (no) Fremgangsmaate til fremstilling av epipodofyllotoksinaltrosid-derivater.
NO901071L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
IS1853B (is) Ný aðferð til að búa til 3-N,N-dísýklóbútýlamínó-8-flúor-3,4-díhýdró-2H-1-bensópýran-5-karboxamíð
NO952676D0 (no) Fremgangsmåte for fremstilling av pumpbare vandige leireblandinger
EE200000674A (et) Parendatud meetod farmatseutiliselt väärtuslike norbensomorfaaniderivaatide valmistamiseks
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
NO903196D0 (no) Fremgangsmaate for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoater.
FI971964A (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
NO167387C (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivat.
NO170578C (no) Fremgangsmaate for fremstilling n,n-dimetylaminometylarylforbindelser
UA25100A (uk) Припрацювальhа суміш
NO881848L (no) Skjult innledning for frekvenshoppet synkronisering.
NO920207D0 (no) Fremgangsmaate for fremstilling av 6-methyl-oestra-4,6-diener

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1040107

Country of ref document: EP

REN Ceased due to non-payment of the annual fee